Jazz Pharmaceuticals Eulerpool News

Jazz Pharmaceuticals Eulerpool News

Jazz Pharmaceuticals Notizie Azioni

Jazz Pharmaceuticals è seguito da molti giornalisti e investitori in tutto il mondo. Qui raccogliamo le più recenti notizie Jazz Pharmaceuticals.

• 4 ottobre ·

  Benzinga
  Assessing Jazz Pharmaceuticals: Insights From 12 Financial Analysts
• 4 ottobre ·

  GuruFocus
  Jazz Pharmaceuticals: Unveiling Growth Potential From Non-Small Cell Lung Cancer Market
• 27 settembre ·

  SeekingAlpha
  Zymeworks Approaching A Moment Of Truth With Zanidatamab
• 19 settembre ·

  SeekingAlpha
  Jazz Pharmaceuticals: Zanidatamab Is A Potential Growth Catalyst
• 18 settembre ·

  Yahoo
  Jazz Pharmaceuticals' (NASDAQ:JAZZ) earnings have declined over five years, contributing to shareholders 16% loss
• 18 settembre ·

  TipRanks
  Jazz Pharmaceuticals (JAZZ) Gets a Buy from Truist Financial
• 16 settembre ·

  Yahoo
  Jazz Pharmaceuticals Presents Updated Phase 2 Data for Zanidatamab Demonstrating Increased mPFS in HER2-Positive Metastatic Gastroesophageal Adenocarcinoma at ESMO 2024
• 16 settembre ·

  Thefly.com
  Jazz Pharmaceuticals presents updated Phase 2 data for zanidatamab
• 15 settembre ·

  Seeking Alpha
  Stock moves reflect downgrade for US economic growth outlook - Goldman
• 12 settembre ·

  Thefly.com
  Truist healthcare analyst holds an analyst/industry conference call